Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Selected Publication:

Wagner, L.
Evaluation of palliative third line treatment in patients with metastatic colorectal cancer
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2024. pp. 81 [OPEN ACCESS]
FullText

 

Authors Med Uni Graz:

Advisor:

Gerger Armin

Riedl Jakob

Altmetrics:

Abstract:

Despite the development of new targeted therapy options for metastatic colorectal cancer (mCRC), the prognosis in advanced disease remains poor. Until recently, only two monotherapies, Regorafenib and TAS-102, were available for palliative third-line treatment. The recently published randomised phase 3 “SUNLIGHT” trial showed that the combination of TAS-102+Bevacizumab (TAS-102+Bev) was superior to TAS-102 monotherapy. However, there is very limited data on the efficacy of this treatment strategy outside of a clinical trial setting.

© Med Uni Graz • Imprint